https://www.selleckchem.com/products/sc75741.html
ith the patient's wishes. Trial registration ClinicalTrials.gov Identifier NCT03013530. Registered 6 January 2017; https//clinicaltrials.gov/ct2/show/NCT03013530 . Cerebral creatine deficiency disorders (CCDD) are inherited metabolic disorders of creatine synthesis and transport. Urine creatine metabolite panel is helpful to identify these disorders. We reviewed electronic patient charts for all patients that underwent urine creatine metabolite panel testing in the metabolic laboratory at our institution. There were 498 tests conducted
Like
Comment
Share
